Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

PARASITIC CLEARANCE AND RECURRENCE RATES AMONG PATIENTS WITH VIVAX MALARIA ON CHLOROQUINE AND PRIMAQUINE THERAPY

NCT01784315 is registered in ClinicalTrials.gov with Ministry of Health, Bhutan as lead sponsor.

NCT NCT01784315
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01784315 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
PARASITIC CLEARANCE AND RECURRENCE RATES AMONG PATIENTS WITH VIVAX MALARIA ON CHLOROQUINE AND PRIMAQUINE THERAPY
Lead sponsor
Ministry of Health, Bhutan
Phase
Observational
Overall status
Unknown status
Start date
March 31, 2013
Completion date
December 31, 2014
Enrollment
50 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

parasitemia